Indrayani Biotech Limited (BOM:526445)

Indrayani Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	2.88	5.82	30.37	15.03	6.79
Short-Term Investments	262.11	296.7	96.58	6.77	-
Cash & Short-Term Investments	265	302.52	126.94	21.8	6.79
Cash Growth	-12.40%	138.31%	482.33%	221.19%	-51.59%
Accounts Receivable	586.9	395.29	299.72	140.99	47.68
Other Receivables	-	245.41	177.15	12.83	14.57
Receivables	672.52	709.17	500.53	153.82	62.25
Inventory	413.42	423.51	122.14	15.32	10.9
Other Current Assets	428.42	14.56	25.62	4.97	11.58
Total Current Assets	1,779	1,450	775.23	195.91	91.52
Property, Plant & Equipment	600.04	593.77	478.56	259.38	252.52
Long-Term Investments	2.48	2.23	2.23	0.01	0.12
Goodwill	233.47	233.47	233.47	38.41	38.41
Other Intangible Assets	0.01	-	0.15	-	-
Long-Term Deferred Tax Assets	2.26	13.56	0.38	-	-
Other Long-Term Assets	64.04	57.46	69.6	20.3	17.98
Total Assets	2,682	2,350	1,560	514.01	400.55
Accounts Payable	235.83	373.9	227.38	58.2	33.36
Accrued Expenses	-	55.3	54.82	22.03	10.89
Short-Term Debt	-	398.51	314.31	111.03	73.83
Current Portion of Long-Term Debt	716.57	12.16	19.44	-	-
Current Portion of Leases	-	7.93	11.25	3.57	-
Current Income Taxes Payable	-	6.19	2.01	-	-
Current Unearned Revenue	-	0.33	0.12	-	-
Other Current Liabilities	72.44	16.4	89.77	-	-
Total Current Liabilities	1,025	870.72	719.1	194.82	118.07
Long-Term Debt	654.15	665.97	293.7	67.85	81.54
Long-Term Leases	-	40.67	63.16	5.5	-
Long-Term Deferred Tax Liabilities	2.76	10.24	0.14	0.14	0.14
Other Long-Term Liabilities	0.75	-	-	-	-
Total Liabilities	1,682	1,588	1,076	268.31	199.75
Common Stock	455.36	455.36	342.27	342.27	342.27
Additional Paid-In Capital	-	126.64	114.01	0.09	-
Retained Earnings	-	48.94	-13.36	-100.72	-145.12
Comprehensive Income & Other	269.73	41.18	15.44	-	0.05
Total Common Equity	725.1	672.12	458.37	241.63	197.2
Minority Interest	274.07	90.54	-67.34	4.06	3.6
Shareholders' Equity	999.16	762.66	483.53	245.7	200.8
Total Liabilities & Equity	2,682	2,350	1,560	514.01	400.55
Total Debt	1,371	1,125	701.86	187.94	155.36
Net Cash (Debt)	-1,106	-822.72	-574.92	-166.15	-148.58
Net Cash Per Share	-24.44	-21.13	-13.22	-4.85	-4.17
Filing Date Shares Outstanding	63.15	45.54	34.23	34.23	34.23
Total Common Shares Outstanding	63.15	45.54	34.23	34.23	34.23
Working Capital	754.51	579.04	56.13	1.08	-26.55
Book Value Per Share	11.48	14.76	13.39	7.06	5.76
Tangible Book Value	491.61	438.65	224.75	203.22	158.79
Tangible Book Value Per Share	7.78	9.63	6.57	5.94	4.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.